{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:26:34Z","timestamp":1783311994354,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,9]]},"DOI":"10.7759\/cureus.53913","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:59:50Z","timestamp":1707494390000},"source":"Crossref","is-referenced-by-count":1,"title":["High-Risk Aortic Plaque in Atrial Fibrillation: A Therapeutic Dilemma"],"prefix":"10.7759","author":[{"given":"Shaniza","family":"Haniff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin","family":"Shive Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawfal","family":"Al-khafaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2016.05.019","article-title":"Use of concomitant aspirin in patients with atrial fibrillation: findings from the ROCKET AF trial","volume":"179","author":"Shah R","year":"2016","unstructured":"Shah R, Hellkamp A, Lokhnygina Y, et al.. Use of concomitant aspirin in patients with atrial fibrillation: findings from the ROCKET AF trial. Am Heart J. 2016, 179:77-86. 10.1016\/j.ahj.2016.05.019","journal-title":"Am Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.30.4.834","article-title":"Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications","volume":"30","author":"Blackshear JL","year":"1999","unstructured":"Blackshear JL, Pearce LA, Hart RG, Zabalgoitia M, Labovitz A, Asinger RW, Halperin JL. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke. 1999, 30:834-40. 10.1161\/01.str.30.4.834","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(90)90024-R","article-title":"Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography","volume":"120","author":"Tunick PA","year":"1990","unstructured":"Tunick PA, Kronzon I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J. 1990, 120:658-60. 10.1016\/0002-8703(90)90024-R","journal-title":"Am Heart J"},{"key":"ref4","article-title":"Thromboembolism from aortic plaque","author":"Pearce BJ","year":"2023","unstructured":"Pearce BJ. Thromboembolism from aortic plaque. UpToDate. 2023,","journal-title":"UpToDate"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0749-4041(09)79239-5","article-title":"Aortic arch plaques and risk of recurrent stroke and death","author":"Moneta GL","year":"2010","unstructured":"Moneta GL. Aortic arch plaques and risk of recurrent stroke and death. Yearbook Vasc Surg. 2010, 251-3. 10.1016\/s0749-4041(09)79239-5","journal-title":"Yearbook Vasc Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5551\/jat.58339","article-title":"Complex aortic arch atherosclerosis in acute ischemic stroke patients with non-valvular atrial fibrillation","volume":"28","author":"Suzuki M","year":"2021","unstructured":"Suzuki M, Furuya K, Ozawa M, et al.. Complex aortic arch atherosclerosis in acute ischemic stroke patients with non-valvular atrial fibrillation. J Atheroscler Thromb. 2021, 28:776-85. 10.5551\/jat.58339","journal-title":"J Atheroscler Thromb"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(97)00449-x","article-title":"Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke","volume":"31","author":"Dressler FA","year":"1998","unstructured":"Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1998, 31:134-8. 10.1016\/s0735-1097(97)00449-x","journal-title":"J Am Coll Cardiol"},{"key":"ref8","unstructured":"Center for Disease Control Leading Causes of Death. (2023). Accessed. August 12, 2023: https:\/\/www.cdc.gov\/stroke\/facts.htm."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-0583","article-title":"Aortic atherosclerotic plaque and long-term prognosis in patients with atrial fibrillation-a transesophageal echocardiography study","volume":"77","author":"Okura H","year":"2013","unstructured":"Okura H, Kataoka T, Yoshiyama M, Yoshikawa J, Yoshida K. Aortic atherosclerotic plaque and long-term prognosis in patients with atrial fibrillation-a transesophageal echocardiography study. Circ J. 2013, 77:68-72. 10.1253\/circj.cj-12-0583","journal-title":"Circ J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.03.016","article-title":"Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study","volume":"169","author":"Sugioka K","year":"2015","unstructured":"Sugioka K, Takagi M, Sakamoto S, et al.. Predictors of silent brain infarction on magnetic resonance imaging in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Am Heart J. 2015, 169:783-90. 10.1016\/j.ahj.2015.03.016","journal-title":"Am Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco P","year":"2006","unstructured":"Amarenco P, Bogousslavsky J, Callahan A 3rd, et al.. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006, 355:549-59. 10.1056\/NEJMoa061894","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605093341902","article-title":"Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke","volume":"334","author":"Amarenco P","year":"1996","unstructured":"Amarenco P, Cohen A, Hommel M, Moulin T, Leys D, Bousser M-G. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996, 334:1216-21. 10.1056\/NEJM199605093341902","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-1342","article-title":"Cardiological aspects of stroke prevention","volume":"79","author":"Fisher M","year":"2015","unstructured":"Fisher M, McAllister M. Cardiological aspects of stroke prevention. Circ J. 2015, 79:271-7. 10.1253\/circj.CJ-14-1342","journal-title":"Circ J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.04.019","article-title":"Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation","volume":"132","author":"Shahid F","year":"2018","unstructured":"Shahid F, Pastori D, Violi F, Lip GY. Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation. Pharmacol Res. 2018, 132:149-59. 10.1016\/j.phrs.2018.04.019","journal-title":"Pharmacol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000178","article-title":"Aortic atherosclerosis: a common source of cerebral emboli, often overlooked!","volume":"23","author":"Ismail I","year":"2016","unstructured":"Ismail I, Agarwal A, Aggarwal S, et al.. Aortic atherosclerosis: a common source of cerebral emboli, often overlooked!. Am J Ther. 2016, 23:e268-72. 10.1097\/MJT.0000000000000178","journal-title":"Am J Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00146-6","article-title":"Transesophageal echocardiographic correlates of clinical risk","volume":"31","author":"Zabalgoitia M","year":"1998","unstructured":"Zabalgoitia M, Halperin JL, Pearce LA, et al.. Transesophageal echocardiographic correlates of clinical risk. J Am Coll Cardiol. 1998, 31:1622-6. 10.1016\/S0735-1097(98)00146-6","journal-title":"J Am Coll Cardiol"},{"key":"ref17","article-title":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"74","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines.  J Am Coll Cardiol. 2019, 74:e177-e232.","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15289","article-title":"Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate","volume":"19","author":"van Gorp RH","year":"2021","unstructured":"van Gorp RH, Dijkgraaf I, Br\u00f6ker V, et al.. Off-target effects of oral anticoagulants - vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate. J Thromb Haemost. 2021, 19:1348-63. 10.1111\/jth.15289","journal-title":"J Thromb Haemost"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106661","article-title":"Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth","volume":"127","author":"Millenaar D","year":"2020","unstructured":"Millenaar D, Bachmann P, B\u00f6hm M, Custodis F, Schirmer SH. Effects of edoxaban and warfarin on vascular remodeling: Atherosclerotic plaque progression and collateral artery growth. Vasc Pharmacol. 2020, 127:10.1016\/j.vph.2020.106661","journal-title":"Vasc Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5551\/jat.17277","article-title":"Effects of medical treatment on the prognosis and risk of embolic events in patients with severe aortic plaque","volume":"20","author":"Nishiga M","year":"2013","unstructured":"Nishiga M, Izumi C, Matsutani H, et al.. Effects of medical treatment on the prognosis and risk of embolic events in patients with severe aortic plaque. J Atheroscler Thromb. 2013, 20:821-9. 10.5551\/jat.17277","journal-title":"J Atheroscler Thromb"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2022.008","article-title":"Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis","volume":"166","author":"Mihaila RG","year":"2022","unstructured":"Mihaila RG. Warfarin involvement, in comparison to NOACs, in the development of systemic atherosclerosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022, 166:150-4. 10.5507\/bp.2022.008","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2043762","article-title":"Warfarin accelerates aortic calcification by upregulating senescence-associated secretory phenotype maker expression","volume":"2020","author":"Wei N","year":"2020","unstructured":"Wei N, Lu L, Zhang H, et al.. Warfarin accelerates aortic calcification by upregulating senescence-associated secretory phenotype maker expression. Oxid Med Cell Longev. 2020, 2020:2043762. 10.1155\/2020\/2043762","journal-title":"Oxid Med Cell Longev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-5-391","article-title":"Atheromatosis of the aortic arch as an occult source of multiple systemic emboli","volume":"114","author":"Tunick PA","year":"1991","unstructured":"Tunick PA, Culliford AT, Lamparello PJ, Kronzon I. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med. 1991, 114:391-2. 10.7326\/0003-4819-114-5-391","journal-title":"Ann Intern Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184036-high-risk-aortic-plaque-in-atrial-fibrillation-a-therapeutic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:50Z","timestamp":1707506330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184036-high-risk-aortic-plaque-in-atrial-fibrillation-a-therapeutic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.53913","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,9]]}}}